672 related articles for article (PubMed ID: 22178577)
1. Platelets and primary haemostasis.
Clemetson KJ
Thromb Res; 2012 Mar; 129(3):220-4. PubMed ID: 22178577
[TBL] [Abstract][Full Text] [Related]
2. GPIbalpha-selective activation of platelets induces platelet signaling events comparable to GPVI activation events.
Gardiner EE; Arthur JF; Shen Y; Karunakaran D; Moore LA; Am Esch JS; Andrews RK; Berndt MC
Platelets; 2010; 21(4):244-52. PubMed ID: 20367574
[TBL] [Abstract][Full Text] [Related]
3. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
Hoylaerts MF
Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
[TBL] [Abstract][Full Text] [Related]
4. Blood platelet biochemistry.
Broos K; De Meyer SF; Feys HB; Vanhoorelbeke K; Deckmyn H
Thromb Res; 2012 Mar; 129(3):245-9. PubMed ID: 22119499
[TBL] [Abstract][Full Text] [Related]
5. GPIb potentiates GPVI-induced responses in human platelets.
Baker J; Griggs RK; Falati S; Poole AW
Platelets; 2004 Jun; 15(4):207-14. PubMed ID: 15203711
[TBL] [Abstract][Full Text] [Related]
6. Platelet collagen receptors.
Clemetson KJ; Clemetson JM
Thromb Haemost; 2001 Jul; 86(1):189-97. PubMed ID: 11487007
[TBL] [Abstract][Full Text] [Related]
7. Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity.
Loyau S; Dumont B; Ollivier V; Boulaftali Y; Feldman L; Ajzenberg N; Jandrot-Perrus M
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):778-85. PubMed ID: 22155453
[TBL] [Abstract][Full Text] [Related]
8. Platelet GPIb complex as a target for anti-thrombotic drug development.
Clemetson KJ; Clemetson JM
Thromb Haemost; 2008 Mar; 99(3):473-9. PubMed ID: 18327394
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of platelet functional alterations in patients with filamin A mutations.
Berrou E; Adam F; Lebret M; Fergelot P; Kauskot A; Coupry I; Jandrot-Perrus M; Nurden A; Favier R; Rosa JP; Goizet C; Nurden P; Bryckaert M
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):e11-8. PubMed ID: 23117662
[TBL] [Abstract][Full Text] [Related]
10. Thrombocytopathy leading to impaired in vivo haemostasis and thrombosis in platelet type von Willebrand disease.
Kaur H; Corscadden K; Ware J; Othman M
Thromb Haemost; 2017 Feb; 117(3):543-555. PubMed ID: 28004055
[TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of platelet activation and development of antiplatelet agents].
Cazenave JP; Gachet C; Lanza F
Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1501-6. PubMed ID: 9092410
[TBL] [Abstract][Full Text] [Related]
12. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
[TBL] [Abstract][Full Text] [Related]
13. [Involvement of platelet collagen receptors in primary hemostasis].
Kralisz U; Stasiak M
Postepy Biochem; 2007; 53(4):344-55. PubMed ID: 19024899
[TBL] [Abstract][Full Text] [Related]
14. Platelet interactions in thrombosis.
Andrews RK; Gardiner EE; Shen Y; Berndt MC
IUBMB Life; 2004 Jan; 56(1):13-8. PubMed ID: 14992375
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein VI is associated with GPIb-IX-V on the membrane of resting and activated platelets.
Arthur JF; Gardiner EE; Matzaris M; Taylor SG; Wijeyewickrema L; Ozaki Y; Kahn ML; Andrews RK; Berndt MC
Thromb Haemost; 2005 Apr; 93(4):716-23. PubMed ID: 15841318
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet glycoprotein Ib and its antithrombotic potential.
Vanhoorelbeke K; Ulrichts H; Van de Walle G; Fontayne A; Deckmyn H
Curr Pharm Des; 2007; 13(26):2684-97. PubMed ID: 17897012
[TBL] [Abstract][Full Text] [Related]
17. Platelet adhesion to collagen.
Nuyttens BP; Thijs T; Deckmyn H; Broos K
Thromb Res; 2011 Jan; 127 Suppl 2():S26-9. PubMed ID: 21193111
[TBL] [Abstract][Full Text] [Related]
18. Biomechanical thrombosis: the dark side of force and dawn of mechano-medicine.
Chen Y; Ju LA
Stroke Vasc Neurol; 2020 Jun; 5(2):185-197. PubMed ID: 32606086
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of von Willebrand factor-GPIb/IX/V interactions as a strategy to prevent arterial thrombosis.
Bonnefoy A; Vermylen J; Hoylaerts MF
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):257-69. PubMed ID: 15030285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]